CovidVax show full list
COVID-19 VACCINE:

DNA

researcher:
DIOSynVax + University of Cambridge + PharmaJet
http://www.diosvax.com/
(UK)
vaccine type: DNA-based
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)
Oct 27CambridgeUni received a multi-million dollar funding for clinical trial using PharmaJet's needle-free system to deliver vaccine (by businesswire.com)
Sep 17CambridgeUni's vaccine has shown excellent safety and immunogenicity in Phase 1-2 trials (by diosvax.com)
Mar 17DIOSynVax's approach can lead to a vaccine candidate for human clinical trials in June (by cam.ac.uk)
Animal Testing updates (pre-clinical trials)
currently no pre-clinical trials info
early development updates
currently no early development info



funding:
£1.9 million from UK government
Aug 26Cambridge's vaccine could start UK clinical trials in Q4 2020 thanks to a £1.9M award from UK govt (by cam.ac.uk)
Aug 26CambridgeUni has received a £1.9m grant from the UK Gov to conduct clinical trials of its vaccine candidate (by clinicaltrialsarena.com)



contact | about | ©2020 CovidVax.org project